Abeona Therapeutics ABEO
NASDAQ ABEO
$6.01 +0.08 (+1.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

Abeona Therapeutics (ABEO) EV to FCF (2011 - 2026)

Analysis

Abeona Therapeutics (ABEO) EV to FCF (2011 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Abeona Therapeutics 342.29 Mn 195.46 Mn 7.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -11.51
Mar 31, 2026 -4.17
Dec 31, 2025 -5.16
Sep 30, 2025 -2.92
Jun 30, 2025 -3.02
Mar 31, 2025 -7.52
Dec 31, 2024 -9.10
Sep 30, 2024 -13.00
Jun 30, 2024 -4.00
Mar 31, 2024 -8.98
Dec 31, 2023 -5.88
Sep 30, 2023 -8.63
Jun 30, 2023 -4.79
Mar 31, 2023 -0.82
Dec 31, 2022 1.98
Sep 30, 2022 0.03
Jun 30, 2022 -0.54
Mar 31, 2022 -84.16
Dec 31, 2021 -23.45
Sep 30, 2021 -259.34